| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.85▼ | 3.85▼ | 3.85▲ | 3.90▼ | 4.05▼ |
| MA10 | 3.85▼ | 3.84▲ | 3.84▲ | 4.04▼ | 4.20▼ |
| MA20 | 3.85▲ | 3.84▲ | 3.85▼ | 4.09▼ | 4.33▼ |
| MA50 | 3.84▲ | 3.89▼ | 3.94▼ | 4.25▼ | 3.91▼ |
| MA100 | 3.84▲ | 3.96▼ | 4.12▼ | 4.30▼ | N/A |
| MA200 | 3.87▼ | 4.12▼ | 4.05▼ | 4.10▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.006▲ | 0.009▲ | -0.032▼ | -0.102▼ |
| RSI | 51.293▲ | 49.329▼ | 44.523▼ | 37.951▼ | 44.368▼ |
| STOCH | 80.370▲ | 63.357 | 52.288 | 17.129▼ | 24.735 |
| WILL %R | -22.222▲ | -56.000 | -29.167 | -78.313▼ | -86.957▼ |
| CCI | 42.692 | 34.121 | 53.200 | -91.178 | -107.622▼ |
| ▲ GAP | $EU Open Gap Up %2 | Set Alert |
|
Friday, July 26, 2024 06:28 AM
GSK (GSK) stock gains as EU backs expanding its authorization for the company's Arexvy RSV shot for those aged 50-59. Read more here.
|
|
Friday, July 26, 2024 05:37 AM
Merck's (MRK) blockbuster product, Keytruda, is endorsed in the EU in combination with Pfizer’s (PFE) Padcev for a type of bladder cancer. Read more here.
|
|
Friday, July 26, 2024 05:16 AM
Q2 2024 Earnings Call Transcript July 25, 2024 Operator: Welcome to AstraZeneca’s Half Year and Q2 Results 2024 Webinar for Investors and Analysts. Before I hand over to AstraZeneca, I’d like to read ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 26/07/24 | 3.92 | 3.92 | 3.795 | 3.85 | 1,080,299 |
| 25/07/24 | 3.83 | 3.89 | 3.67 | 3.82 | 1,111,500 |
| 24/07/24 | 4.01 | 4.04 | 3.81 | 3.83 | 943,911 |
| 23/07/24 | 4.00 | 4.05 | 3.93 | 4.01 | 563,180 |
| 22/07/24 | 4.01 | 4.06 | 3.89 | 3.99 | 880,400 |
| 19/07/24 | 3.97 | 4.01 | 3.88 | 3.99 | 1,184,000 |
| 18/07/24 | 4.19 | 4.23 | 3.98 | 3.99 | 1,111,060 |
| 17/07/24 | 4.35 | 4.35 | 4.11 | 4.16 | 1,606,500 |
| 16/07/24 | 4.43 | 4.43 | 4.27 | 4.37 | 975,200 |
| 15/07/24 | 4.39 | 4.43 | 4.33 | 4.39 | 770,558 |
|
|
||||
|
|
||||
|
|